Phase III SINDAS: Interim Analysis of First-line EGFR TKI With vs Without SBRT in Patients With EGFR-Mutated Oligometastatic NSCLC

Expert faculty reviews key clinical trials in relapsed extensive-stage small-cell lung cancer from the 2020 World Conference on Lung Cancer, from Clinical Care Options (CCO)

Nicolas Girard, MD, PhD Released: March 1, 2021

Podcast episode with expert insights on new data from WCLC 2020 helping to improve outcomes for patients with early-stage lung cancer, from Clinical Care Options (CCO)

Jamie E. Chaft, MD Released: February 24, 2021

Get expert insights from Clinical Care Options (CCO) on how to talk to your patients with lung or thyroid cancer about precision medicine

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP Released: February 23, 2021

In this slideset from Clinical Care Options (CCO), Joel W. Neal, MD, PhD discusses antibody-drug conjugates within the clinical trial setting in NSCLC

Joel W. Neal, MD, PhD Released: February 16, 2021